The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|80|5-6|333-340

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.5-6, 2011-07, pp. : 333-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Value of F-18 FDG PET/CT for Malignant Pleural Effusion in Non-Small Cell Lung Cancer Patients

By  

Oncology Research and Treatment, Vol. 34, Iss. 6, 2011-05 ,pp. : 298-303

Karger

Access to resources Recommend Favorite

Interleukin 17A genetic variations and susceptibility to non‐small cell lung cancer

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 3, 2015-03 ,pp. : 194-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection and Typing of Human Papillomavirus in Non-Small Cell Lung Cancer

By  

Respiration, Vol. 71, Iss. 1, 2004-02 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non–small cell lung cancer

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3367-3376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Refining the assessment of the sensitivity and specificity of diagnostic tests, with applications to prostate cancer screening and non-small cell lung cancer staging

By Berger Vance W.   Semanick Lisa  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 18, Iss. 1, 2005-07 ,pp. : 64-70

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite